Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1748810Generated: October 30, 2026

Ammonium Chloride → rac-ethyl 2-((4S,6S,7R)-4-(4-chloro-2-methylphenyl)-1,3,7-trimethyl-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepin-6-yl)acetate

https://huagongshe.com/reaction/1748810

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAmmonium ChlorideHCID 25517—
ReactantSodium borohydrideHCID 4311764—
Reactantethyl 2-(4-(4-chloro-2-methylphenyl)-1,3,7-trimethyl-4,6-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-6-yl)acetateHCID 86724138—
SolventMethanolHCID 887—
Productrac-ethyl 2-((4R,6S,7R)-4-(4-chloro-2-methylphenyl)-1,3,7-trimethyl-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepin-6-yl)acetateHCID 13663467519%
Productrac-ethyl 2-((4S,6S,7R)-4-(4-chloro-2-methylphenyl)-1,3,7-trimethyl-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepin-6-yl)acetateHCID 13663468149%

Reaction Steps

A solution of ethyl 2-(4-(4-chloro-2-methylphenyl)-1,3,7-trimethyl-4,6-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-6-yl)acetate (0.85 g, 1.97 mmol) in MeOH (3.94 mL) was cooled to about 0° C. To the reaction mixture was added sodium tetrahydroborate (0.298 g, 7.88 mmol) portionwise. The reaction mixture was allowed to slowly warm to ambient temperature and stirred for about 16 h. The reaction mixture was cooled to about 0° C. and then saturated aqueous NH4Cl (10 mL) was added. The mixture was partially concentrated under reduced pressure and EtOAc (20 mL) was added. The layers were separated and the aqueous layer was back extracted with EtOAc (10 mL). The combined organic layers were dried over MgSO4, filtered and concentrated under reduced pressure. The crude material was purified by column chromatography (SiO2, EtOAc/DCM 100:0 to 0:50) to afford rac-ethyl 2-((4R,6S,7R)-4-(4-chloro-2-methylphenyl)-1,3,7-trimethyl-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepin-6-yl)acetate (0.15 g, 0.37 mmol, 19%) LC-MS (Table 1, Method g) Rt=2.58, m/z 408 (M+H)+and rac-ethyl 2-((4S,6S,7R)-4-(4-chloro-2-methylphenyl)-1,3,7-trimethyl-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepin-6-yl)acetate (0.39 g, 0.97 mmol, 49%) LC-MS (Table 1, Method g) Rt=2.48, m/z 408 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09150592B2
Source datasetuspto-grants-2015_10
ORD IDord-a4dfb2de52934e6eb97cc443576b5954
Source noteuspto-grants-2015_10